GreyBird Ventures

Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.

Platomics provides a software infrastructure for a secure, state-of-the-art, certified analysis of data from genetic tests. Platomics connects physicians, clinical labs and providers of genetic kits. We are an enabler for the development of a standardized genetic testing market. Platomics helps the stakeholders of the genetic testing market to meet the upcoming requirements of the "In Vitro Diagnostic Regulations"

GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.

Jiangxi Zhongke Jiufeng Wisdom Medical Technology Co., Ltd. was established in May 2015. Under the strong support of the Jiangxi Provincial Party Committee Government, Nanchang Municipal Government and the High-tech Zone Government, the former Siemens Northeast Asia (Greater China + Korea) Medical Mr. Wu Wenhui, the president, led the team of domestic and international first-class science and technology experts, hospital management experts and industry senior professional managers.

Ceres Nanosciences, Inc. is a privately held life sciences company based in Manassas, Virginia, specializing in the research, development, and commercialization of sample preparation products and diagnostic tests. Utilizing its proprietary Nanotrap technology, Ceres captures, enriches, and preserves biomarkers, facilitating the early detection of various diseases, including cancer, cardiac conditions, and infectious diseases. The company's offerings include a toolset designed for the enrichment of low abundance biomarkers found in complex biofluids such as serum, plasma, urine, and saliva. Among its products is the Nanotrap Lyme Antigen Test, which directly measures Lyme antigens in urine using a Western Blot format. Ceres is funded through federal agency grants and industry collaborations, and it aims to enhance patient outcomes while reducing healthcare costs through innovative diagnostic solutions.

Atlas5D, Inc. is a technology company based in Cambridge, Massachusetts, focused on developing solutions for individuals with reduced mobility. Founded in 2011, the company specializes in creating sensors that assess brain, neuromuscular, and cardiovascular conditions without the need for wearable devices. Its flagship product, Echo5D, is an ambient sensor that passively measures human movement and behavior, providing continuous monitoring of patient ambulation and dexterity in various settings, including the home. This innovative approach allows caregivers and clinicians to gain valuable insights into patients' daily activities and health status, facilitating better management of conditions such as multiple sclerosis and Parkinson's disease. Atlas5D serves multiple sectors, including biotechnology, pharmaceuticals, insurance, government, and healthcare, and its founders bring a wealth of experience from prestigious institutions and organizations.